{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:51:43Z","timestamp":1783003903750,"version":"3.54.5"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P1-0170"],"award-info":[{"award-number":["P1-0170"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P1-0207"],"award-info":[{"award-number":["P1-0207"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cbi.2025.111787","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:01:20Z","timestamp":1761058880000},"page":"111787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The role of age and sex in paraoxonase 1 activity in patients with Alzheimer's dementia"],"prefix":"10.1016","volume":"422","author":[{"given":"Bo\u0161tjan","family":"Petri\u010d","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica Gregori\u010d","family":"Kramberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita","family":"Dol\u017ean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreja","family":"Emer\u0161i\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Goli\u010dnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrijana","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Kri\u017eaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7922-9745","authenticated-orcid":false,"given":"Aljo\u0161a","family":"Bavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2025.111787_bib1","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/archneur.59.11.1764","article-title":"Survival following a diagnosis of alzheimer disease","volume":"59","author":"Brookmeyer","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.cbi.2025.111787_bib2","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/j.jalz.2014.04.009","article-title":"Smoking and increased Alzheimer's disease risk: a review of potential mechanisms","volume":"10","author":"Durazzo","year":"2014","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.cbi.2025.111787_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/lio2.65","article-title":"Hearing loss as a risk factor for dementia: a systematic review","volume":"2","author":"Thomson","year":"2017","journal-title":"Laryngoscope Investig. Otolaryngol."},{"key":"10.1016\/j.cbi.2025.111787_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz4564","article-title":"APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia","volume":"13","author":"Sienski","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cbi.2025.111787_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13024-021-00452-5","article-title":"Protective genes and pathways in Alzheimer's disease: moving towards precision interventions","volume":"16","author":"Seto","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cbi.2025.111787_bib6","doi-asserted-by":"crossref","first-page":"15132","DOI":"10.18632\/oncotarget.23738","article-title":"The genes associated with early-onset Alzheimer's disease","volume":"9","author":"Dai","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2025.111787_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000007969","article-title":"Neurofibrillary tangles and Alzheimer's disease","volume":"40","author":"Brion","year":"1998","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.cbi.2025.111787_bib8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.cbi.2025.111787_bib9","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJMoa2310168","article-title":"Biomarker changes during 20 years preceding alzheimer's disease","volume":"390","author":"Jia","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2025.111787_bib10","article-title":"CSF biomarkers for alzheimer's disease diagnosis","volume":"2010","author":"Anoop","year":"2010","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.cbi.2025.111787_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8590578","article-title":"The role of reactive oxygen species in the pathogenesis of alzheimer's disease, parkinson's disease, and huntington's disease: a mini review","volume":"2016","author":"Manoharan","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.cbi.2025.111787_bib12","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.drudis.2020.12.004","article-title":"Role of reactive oxygen species in the progression of Alzheimer's disease","volume":"26","author":"Bhatt","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.cbi.2025.111787_bib13","article-title":"Alzheimer's disease drug development pipeline","volume":"10","author":"Cummings","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.cbi.2025.111787_bib14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4103\/1947-2714.103310","article-title":"Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases","volume":"4","author":"Litvinov","year":"2012","journal-title":"N. Am. J. Med. Sci."},{"key":"10.1016\/j.cbi.2025.111787_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25245980","article-title":"The structure and function of Paraoxonase-1 and its comparison to Paraoxonase-2 and -3","volume":"25","author":"Taler-Ver\u010di\u010d","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2025.111787_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cbi.2010.03.033","article-title":"Human PON1, a biomarker of risk of disease and exposure","volume":"187","author":"Furlong","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111787_bib17","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00726-012-1321-z","article-title":"Paraoxonase 1 and homocysteine metabolism","volume":"43","author":"Per\u0142a-Kaj\u00e1n","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.cbi.2025.111787_bib18","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1464-410X.2010.09888.x","article-title":"Paraoxonase-1 is only present in traceable amounts in seminal fluid and does not show any relationship with Male subfertility","volume":"108","author":"Marsillach","year":"2011","journal-title":"BJU Int."},{"key":"10.1016\/j.cbi.2025.111787_bib19","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/rda.13015","article-title":"Paraoxonase 1 (PON1) activity in serum, follicular fluid and seminal plasma of sheep","volume":"52","author":"Pradie\u00e9","year":"2017","journal-title":"Reprod. Domest. Anim."},{"key":"10.1016\/j.cbi.2025.111787_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9050456","article-title":"Arylesterase activity of Paraoxonase-1 in serum and cerebrospinal fluid of patients with alzheimer's disease and vascular dementia","volume":"9","author":"Romani","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.cbi.2025.111787_bib21","doi-asserted-by":"crossref","first-page":"74.e1","DOI":"10.1016\/j.atherosclerosis.2005.08.026","article-title":"Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes","volume":"187","author":"Rosenblat","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cbi.2025.111787_bib22","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1194\/jlr.M400511-JLR200","article-title":"Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities","volume":"46","author":"Draganov","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cbi.2025.111787_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-6148-10-74","article-title":"Serum paraoxonase 1 (PON1) measurement: an update","volume":"10","author":"Ceron","year":"2014","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.cbi.2025.111787_bib24","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1007\/s12010-017-2424-5","article-title":"Towards understanding the catalytic mechanism of human paraoxonase 1: experimental and in silico mutagenesis studies","volume":"182","author":"Tripathy","year":"2017","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.cbi.2025.111787_bib25","series-title":"A Multi-Omics Analysis of PON1 Lactonase Activity in Relation to Human Health and Disease","first-page":"1","author":"Petri\u010d","year":"2020"},{"key":"10.1016\/j.cbi.2025.111787_bib26","first-page":"1","article-title":"Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity","volume":"8","author":"Costa","year":"2003","journal-title":"Biomarkers Biochem. Indic. Expo. Response, Susceptibility to Chem."},{"key":"10.1016\/j.cbi.2025.111787_bib27","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1021\/bi047440d","article-title":"Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase","volume":"44","author":"Khersonsky","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2025.111787_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12020399","article-title":"Investigation of Paraoxonase-1 genotype and enzyme-kinetic parameters in the context of cognitive impairment in parkinson's disease","volume":"12","author":"Petri\u010d","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.cbi.2025.111787_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110601","article-title":"Paraoxonase 1 activity in patients with alzheimer disease: systematic review and meta-analysis","volume":"382","author":"Zuin","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111787_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pjnns.2016.07.002","article-title":"The relationship between serum paraoxonase levels and carotid atherosclerotic plaque formation in Alzheimer's patients","volume":"50","author":"Arslan","year":"2016","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.cbi.2025.111787_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JAD-143096","article-title":"Higher levels of oxidized low density lipoproteins in Alzheimer's disease patients: roles for platelet activating factor acetyl hydrolase and paraoxonase-1","volume":"46","author":"Bacchetti","year":"2015","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.cbi.2025.111787_bib32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2002.tb04802.x","article-title":"Paraoxonase 1 activity: a new vascular marker of dementia?","volume":"977","author":"Dantoine","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cbi.2025.111787_bib33","first-page":"2820","article-title":"Paraoxonase and arylesterase activities in serum of patients with alzheimer disease in gorgan, north east of Iran","volume":"24","author":"Shakeri","year":"2016","journal-title":"Transylv Rev"},{"key":"10.1016\/j.cbi.2025.111787_bib34","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2020.200516","article-title":"Serum HDL associated antioxidant activity in alzheimer's disease: paraoxonase1 and dysfunctional HDL","volume":"66","author":"Varlibas","year":"2020","journal-title":"Clin. Lab."},{"key":"10.1016\/j.cbi.2025.111787_bib35","first-page":"529","article-title":"No title","volume":"50","author":"Zengi","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cbi.2025.111787_bib36","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1159\/000017195","article-title":"Evaluation of serum-lipid-related cardiovascular risk factors in alzheimer's disease","volume":"10","author":"K\u00e1lm\u00e1n","year":"1999","journal-title":"Dement. Geriatr. Cogn. Disord"},{"key":"10.1016\/j.cbi.2025.111787_bib37","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/320600","article-title":"Effects of 5\u2019 regulatory-region polymorphisms on paraoxonase-gene (PON1) expression","volume":"68","author":"Brophy","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cbi.2025.111787_bib38","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0090-9556(24)15082-9","article-title":"Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters","volume":"28","author":"Billecke","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2025.111787_bib39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neurobiolaging.2007.05.021","article-title":"Association study of the paraoxonase 1 gene with the risk of developing Alzheimer's disease","volume":"30","author":"Chapuis","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cbi.2025.111787_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000113709","article-title":"Polymorphisms at the paraoxonase 1 L55M and Q192R loci affect the pathophysiology of Alzheimer's disease: emphasis on the cholinergic system and beta-amyloid levels","volume":"5","author":"Leduc","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.cbi.2025.111787_bib41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(02)01437-4","article-title":"Different pattern of association of paraoxonase Gln192\u2192Arg polymorphism with sporadic late-onset Alzheimer's disease and coronary artery disease","volume":"339","author":"Scacchi","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cbi.2025.111787_bib42","doi-asserted-by":"crossref","first-page":"204.e13","DOI":"10.1016\/j.neurobiolaging.2010.08.010","article-title":"Paraoxonase-1 polymorphisms in Alzheimer's disease, Parkinson's disease, and AD-PD spectrum diseases","volume":"33","author":"Wingo","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cbi.2025.111787_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neulet.2006.08.074","article-title":"Association analysis of the paraoxonase-1 gene with Alzheimer's disease","volume":"408","author":"Cellini","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cbi.2025.111787_bib44","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1034\/j.1600-0404.2001.103005304.x","article-title":"Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia","volume":"103","author":"Zuliani","year":"2001","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.cbi.2025.111787_bib45","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00018-003-3018-7","article-title":"Cholesterol homeostasis and function in neurons of the central nervous system","volume":"60","author":"Pfrieger","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cbi.2025.111787_bib46","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI115288","article-title":"Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation","volume":"88","author":"Linton","year":"1991","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cbi.2025.111787_bib47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jsbmb.2018.12.009","article-title":"On the fluxes of side-chain oxidized oxysterols across blood-brain and blood-CSF barriers and origin of these steroids in CSF","volume":"188","author":"Bj\u00f6rkhem","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cbi.2025.111787_bib48","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1124\/jpet.118.254201","article-title":"Apolipoprotein A-I crosses the blood-brain barrier through clathrin-independent and cholesterol-mediated endocytosis","volume":"369","author":"Zhou","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2025.111787_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206478","article-title":"Protein variability in cerebrospinal fluid and its possible implications for neurological protein biomarker research","volume":"13","author":"Schilde","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2025.111787_bib50","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.biocel.2016.06.008","article-title":"Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases","volume":"81","author":"Castellazzi","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cbi.2025.111787_bib51","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s11745-999-0478-1","article-title":"Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo","volume":"34","author":"Bassett","year":"1999","journal-title":"Lipids"},{"key":"10.1016\/j.cbi.2025.111787_bib52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/ADR-190165","article-title":"Apolipoprotein A1 in cerebrospinal fluid is insufficient to distinguish alzheimer's disease from other dementias in a naturalistic, clinical setting","volume":"4","author":"Stoye","year":"2020","journal-title":"J. Alzheimer\u2019s Dis. Reports"},{"key":"10.1016\/j.cbi.2025.111787_bib53","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.redox.2018.01.001","article-title":"Administration of exercise-conditioned plasma alters muscle catalase kinetics in rat: an argument for in vivo-like K(m) instead of in vitro-like v(max)","volume":"15","author":"Veskoukis","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.cbi.2025.111787_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12020316","article-title":"Genetic polymorphisms in oxidative stress and inflammatory pathways as potential biomarkers in alzheimer's disease and dementia","volume":"12","author":"Vogrinc","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.cbi.2025.111787_bib55","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pep.2005.07.021","article-title":"Cloning, purification, and refolding of human paraoxonase-3 expressed in Escherichia coli and its characterization","volume":"46","author":"Lu","year":"2006","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.cbi.2025.111787_bib56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/bmb.20479","article-title":"Exact and approximate solutions for the decades-old michaelis-menten equation: progress-curve analysis through integrated rate equations","volume":"39","author":"Goli\u010dnik","year":"2011","journal-title":"Biochem. Mol. Biol. Educ."},{"key":"10.1016\/j.cbi.2025.111787_bib57","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/jtbi.1997.0425","article-title":"Closed form solution for time-dependent enzyme kinetics","volume":"187","author":"Schnell","year":"1997","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.cbi.2025.111787_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bpc.2016.09.004","article-title":"On the estimation errors of KM and V from time-course experiments using the michaelis\u2013menten equation","volume":"219","author":"Stroberg","year":"2016","journal-title":"Biophys. Chem."},{"issue":"2","key":"10.1016\/j.cbi.2025.111787_bib59","doi-asserted-by":"crossref","DOI":"10.17344\/acsi.2022.7359","article-title":"iFIT: an automated web tool for determining enzyme-kinetic parameters based on the high-curvature region of progress curves","volume":"69","author":"Petri\u010d","year":"2022","journal-title":"Acta Chim. Slov."},{"key":"10.1016\/j.cbi.2025.111787_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27041306","article-title":"The removal of time-concentration data points from progress curves improves the determination of k(m): the example of paraoxonase 1","volume":"27","author":"Petri\u010d","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2025.111787_bib61","article-title":"Insect protein-based diet as potential risk of allergy in dogs","volume":"11","author":"Premrov Bajuk","year":"2021","journal-title":"Anim. an Open Access J. from MDPI"},{"key":"10.1016\/j.cbi.2025.111787_bib62","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1039\/D3FO05297D","article-title":"Improvement of fruit juice quality: novel endo-polygalacturonase II from Aspergillus tubingensis FAT 43 for enhanced liquefaction{,} clarification{,} and antioxidant potential","volume":"15","author":"Pavlovi\u0107","year":"2024","journal-title":"Food Funct."},{"key":"10.1016\/j.cbi.2025.111787_bib63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JAD-2011-110284","article-title":"Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease","volume":"26","author":"Torres","year":"2011","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.cbi.2025.111787_bib64","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/jnc.13240","article-title":"Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: a pilot study","volume":"135","author":"Cervellati","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2025.111787_bib65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.17219\/acem\/111377","article-title":"Paraoxonase 1 decline and lipid peroxidation rise reflect a degree of brain atrophy and vascular impairment in dementia","volume":"29","author":"Bednarz-Misa","year":"2020","journal-title":"Adv. Clin. Exp. Med. Off. Organ Wroclaw Med. Univ."},{"key":"10.1016\/j.cbi.2025.111787_bib66","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3233\/JAD-210137","article-title":"Paraoxonase 1, B vitamins supplementation, and mild cognitive impairment","volume":"81","author":"Per\u0142a-Kaj\u00e1n","year":"2021","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.cbi.2025.111787_bib67","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1196\/annals.1395.022","article-title":"Age-related paraoxonase activity changes in Turkish population","volume":"1100","author":"Saruhan","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cbi.2025.111787_bib68","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1054\/plef.2001.0320","article-title":"Study of the paraoxonase and platelet-activating factor acetylhydrolase activities with aging","volume":"65","author":"Milochevitch","year":"2001","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.cbi.2025.111787_bib69","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.exger.2003.08.001","article-title":"Study of factors influencing the decreased HDL associated PON1 activity with aging","volume":"39","author":"Seres","year":"2004","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.cbi.2025.111787_bib70","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/gerona\/61.6.541","article-title":"Paraoxonase activity and genotype predispose to successful aging","volume":"61","author":"Marchegiani","year":"2006","journal-title":"J. Gerontol. A. Biol. Sci. Med. Sci."},{"key":"10.1016\/j.cbi.2025.111787_bib71","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2005.06.012","article-title":"Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydryl groups","volume":"185","author":"Jaouad","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cbi.2025.111787_bib72","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1038\/s41598-021-86231-0","article-title":"Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients","volume":"11","author":"Grzegorzewska","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2025.111787_bib73","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1016\/j.atherosclerosis.2021.06.610","article-title":"A way to engage HDL functionality by substituting paraoxonase 1 activity for HDL cholesterol in the commonly used atherogenic ratios: new risk factors for improved identification of coronary artery disease risk","volume":"331","author":"Mahrooz","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cbi.2025.111787_bib74","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.numecd.2023.05.020","article-title":"Can HDL cholesterol be replaced by paraoxonase 1 activity in the prediction of severe coronary artery disease in patients with type 2 diabetes?","volume":"33","author":"Mahrooz","year":"2023","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.cbi.2025.111787_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2023.112211","article-title":"Dietary proteins modulate high-density lipoprotein characteristics in a sex-specific way in apoe-deficient mice","volume":"116","author":"Mart\u00ednez-Beamonte","year":"2023","journal-title":"Nutrition"},{"key":"10.1016\/j.cbi.2025.111787_bib76","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1194\/jlr.P800070-JLR200","article-title":"Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes \u2217[S]","volume":"50","author":"Connelly","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cbi.2025.111787_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16183329","article-title":"Decrease in HDL-C is associated with age and household income in adults from the Korean national health and nutrition examination survey 2017: correlation analysis of low HDL-C and poverty","volume":"16","author":"Cho","year":"2019","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.cbi.2025.111787_bib78","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1038\/s41598-017-05415-9","article-title":"Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer","volume":"7","author":"Sirni\u00f6","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2025.111787_bib79","first-page":"A05","article-title":"Cardiovascular risk according to plasma apolipoprotein and lipid profiles in a Canadian first nation","volume":"8","author":"Riediger","year":"2011","journal-title":"Prev. Chronic Dis."},{"key":"10.1016\/j.cbi.2025.111787_bib80","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/1873-3468.13950","article-title":"Apolipoprotein A-I in mouse cerebrospinal fluid derives from the liver and intestine via plasma high-density lipoproteins assembled by ABCA1 and LCAT","volume":"595","author":"Tsujita","year":"2021","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cbi.2025.111787_bib81","doi-asserted-by":"crossref","DOI":"10.1186\/s12987-020-0173-2","article-title":"Increased age and male sex are independently associated with higher frequency of blood\u2013cerebrospinal fluid barrier dysfunction using the albumin quotient","volume":"17","author":"Castellazzi","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.cbi.2025.111787_bib82","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.96155.3","article-title":"Age-related decline in blood-brain barrier function is more pronounced in males than females in parietal and temporal regions","volume":"13","author":"Shao","year":"2024","journal-title":"eLife"},{"key":"10.1016\/j.cbi.2025.111787_bib83","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.cbi.2025.111787_bib84","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2025.111787_bib85","first-page":"138","article-title":"Blood-brain barrier permeability in aging and alzheimer's disease","volume":"1","author":"Rosenberg","year":"2014","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.cbi.2025.111787_bib86","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s12264-017-0193-3","article-title":"Comorbidity burden of dementia: a hospital-based retrospective study from 2003 to 2012 in seven cities in China","volume":"33","author":"Wang","year":"2017","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.cbi.2025.111787_bib87","doi-asserted-by":"crossref","DOI":"10.1007\/s41999-025-01288-8","article-title":"Comorbidities and comorbidity burden in patients with neurocognitive disorders: findings from the MEMORA cohort study","author":"Temedda","year":"2025","journal-title":"Eur. Geriatr. Med"},{"key":"10.1016\/j.cbi.2025.111787_bib88","first-page":"508","article-title":"Gender differences in the relation between comorbidity and mortality of patients with Alzheimer's disease","volume":"53","author":"Gambassi","year":"1999","journal-title":"Systematic Assessment of Geriatric drug use via Epidemiology (SAGE) Study Group., Neurology"},{"key":"10.1016\/j.cbi.2025.111787_bib89","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bcp.2010.11.008","article-title":"Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on","volume":"81","author":"Costa","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111787_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20042813","article-title":"Modulatory effect of lifestyle-related, environmental and genetic factors on Paraoxonase-1 activity: a review","volume":"20","author":"Kunachowicz","year":"2023","journal-title":"Int. J. Environ. Res. Publ. Health"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927972500417X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927972500417X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:19:17Z","timestamp":1778635157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000927972500417X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":90,"alternative-id":["S000927972500417X"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111787","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of age and sex in paraoxonase 1 activity in patients with Alzheimer's dementia","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111787"}}